Gsa Capital Partners LLP Eye Point Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.37 - $7.2 $57,166 - $173,671	24,121 Added 110.0%	46,050 $161,000
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $152,625 - $243,850	21,929 New	21,929 $173,000
Q1 2021 May 10, 2021	SELL	$8.89 - $14.92 $925,351 - $1.55 Million	-104,089 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$3.7 - $6.58 $385,129 - $684,905	104,089 New	104,089 $685,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.